Nature

Nuclear-fusion firm says plant will deliver electricity to grid – but big questions remain

Commonwealth Fusion Systems published several papers detailing the design of its ARC fusion power plant.

Fusion energy is suddenly flush with cash. Troy Carter knows that won’t be enough

Oak Ridge's director of fusion energy explains why the global race to build the world’s first fusion plant still depends on ...
Gadget Review on MSN

South Korea's "artificial sun" ran for 102 seconds, just changed the global energy game

South Korea's KSTAR reactor achieved 102-second plasma stability, marking a crucial breakthrough toward commercial fusion ...
Zacks Investment Research on MSN

Oklo strengthens reactor development with ARMEC acquisition

Advanced nuclear technology company Oklo Inc. OKLO has strengthened its path toward commercialization through the acquisition of ARMEC, a precision manufacturing and engineering firm based in Oak ...
Las Vegas Sun

Oklo Acquires ARMEC to Expand Vertically Integrated Manufacturing Capabilities for Advanced Reactor and Fuel-Manufacturing Programs

Oklo Inc. (NYSE: OKLO) ("Oklo"), an advanced nuclear technology company, today announced that it has acquired ARMEC, a precision manufacturing and engineering firm based in Oak Ridge, Tennessee. The ...

Trump can't stop America's clean-energy boom: Here's why — and how

Since returning to office in January 2025, Trump has sought to roll back many of the clean-energy incentives introduced under ...

There’s no AI boom without an energy boom

There aren't enough electricity or grid connections to meet surging power demands for AI and data centres. Read more at ...

Scientists Recreate a Nuclear Fireball and Uncover Fallout’s Hidden Chemistry

By recreating a nuclear fireball, scientists uncovered unexpected chemistry that could change how radioactive fallout is understood.

Assessing BioNTech (BNTX) Valuation After Recent Share Price Weakness And Conflicting Growth Signals

BioNTech (BNTX) is back in focus after recent trading left the stock at a last close of US$88.08, with investors weighing its cancer and infectious disease pipeline against current revenue and ...